Quanterix (QTRX) Cash from Investing Activities (2017 - 2026)
Quanterix (QTRX) posted Cash from Investing Activities of $25.3 million for Q1 2026, up 199.36% on a QoQ basis from $8.4 million in Q4 2025, and down 22.89% year-over-year from $32.8 million in Q1 2025.
Quanterix (QTRX) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Quanterix's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at $25.3 million for Q1 2026.
- Quarterly Cash from Investing Activities fell 22.89% year-over-year to $25.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.7 million (down 28.41% YoY) and the FY2025 annual result came in at $50.2 million, up 161.06% from the prior year.
- Cash from Investing Activities was $25.3 million for Q1 2026 at Quanterix, up from $8.4 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $61.9 million in Q2 2025 and bottomed at -$126.1 million in Q3 2023.
- A 5-year average of -$9.8 million and a median of -$815000.0 in 2022 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 960.05% in 2024, while the deepest fall reached 80190.44% in 2024.
- Quanterix's Cash from Investing Activities stood at -$1.6 million in 2022, then tumbled by 1240.19% to -$21.4 million in 2023, then soared by 251.5% to $32.4 million in 2024, then slumped by 73.94% to $8.4 million in 2025, then jumped by 199.36% to $25.3 million in 2026.
- Business Quant data shows QTRX's Cash from Investing Activities at $25.3 million in Q1 2026, $8.4 million in Q4 2025, and -$52.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.15 Bn | 176.85 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.85 Bn | 125.98 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.66 Bn | 67.21 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.18 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Quanterix | 175.00 Mn | 75.73 Mn | 15.57 Mn | 25.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.26 Mn |
| Mar 31, 2026 | 25.26 Mn |
| Dec 31, 2025 | 8.44 Mn |
| Dec 31, 2025 | 8.44 Mn |
| Sep 30, 2025 | -52.85 Mn |
| Sep 30, 2025 | -52.85 Mn |
| Jun 30, 2025 | 61.88 Mn |
| Jun 30, 2025 | 61.88 Mn |
| Mar 31, 2025 | 32.76 Mn |
| Mar 31, 2025 | 32.76 Mn |
| Dec 31, 2024 | 32.38 Mn |
| Dec 31, 2024 | 32.38 Mn |
| Sep 30, 2024 | -12.43 Mn |
| Sep 30, 2024 | -12.43 Mn |
| Jun 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 6.98 Mn |
| Mar 31, 2024 | -109.20 Mn |
| Mar 31, 2024 | -109.20 Mn |
| Dec 31, 2023 | -21.38 Mn |
| Dec 31, 2023 | -21.38 Mn |